Results
|
721.
|
An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancer. [electronic resource] by
- Esteva, Francisco J
- Franco, Sandra X
- Hagan, Maura K
- Brewster, Abenaa M
- Somer, Robert A
- Williams, Will
- Florance, Allison M
- Turner, Simon
- Stein, Steven
- Perez, Alejandra
Producer: 20140213
In:
The oncologist vol. 18
Availability: No items available.
|
|
722.
|
|
|
723.
|
|
|
724.
|
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. [electronic resource] by
- Fearon, Abbie E
- Carter, Edward P
- Clayton, Natasha S
- Wilkes, Edmund H
- Baker, Ann-Marie
- Kapitonova, Ekaterina
- Bakhouche, Bakhouche A
- Tanner, Yasmine
- Wang, Jun
- Gadaleta, Emanuela
- Chelala, Claude
- Moore, Kate M
- Marshall, John F
- Chupin, Juliette
- Schmid, Peter
- Jones, J Louise
- Lockley, Michelle
- Cutillas, Pedro R
- Grose, Richard P
Producer: 20190618
In:
Cell reports vol. 22
Availability: No items available.
|
|
725.
|
|
|
726.
|
|
|
727.
|
Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis. [electronic resource] by
- Kim, Joseph M
- Miller, Jacob A
- Kotecha, Rupesh
- Chao, Samuel T
- Ahluwalia, Manmeet S
- Peereboom, David M
- Mohammadi, Alireza M
- Barnett, Gene H
- Murphy, Erin S
- Vogelbaum, Michael A
- Angelov, Lilyana
- Abraham, Jame
- Moore, Halle
- Budd, G Thomas
- Suh, John H
Producer: 20200819
In:
Neuro-oncology vol. 21
Availability: No items available.
|
|
728.
|
|
|
729.
|
|
|
730.
|
|
|
731.
|
|
|
732.
|
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma. [electronic resource] by
- Reardon, David A
- Groves, Morris D
- Wen, Patrick Y
- Nabors, Louis
- Mikkelsen, Tom
- Rosenfeld, Steve
- Raizer, Jeffrey
- Barriuso, Jorge
- McLendon, Roger E
- Suttle, A Benjamin
- Ma, Bo
- Curtis, C Martin
- Dar, Mohammed M
- de Bono, Johann
Producer: 20130930
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
733.
|
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. [electronic resource] by
- Untch, Michael
- Loibl, Sibylle
- Bischoff, Joachim
- Eidtmann, Holger
- Kaufmann, Manfred
- Blohmer, Jens-Uwe
- Hilfrich, Jörn
- Strumberg, Dirk
- Fasching, Peter A
- Kreienberg, Rolf
- Tesch, Hans
- Hanusch, Claus
- Gerber, Bernd
- Rezai, Mahdi
- Jackisch, Christian
- Huober, Jens
- Kühn, Thorsten
- Nekljudova, Valentina
- von Minckwitz, Gunter
Producer: 20120320
In:
The Lancet. Oncology vol. 13
Availability: No items available.
|
|
734.
|
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts. [electronic resource] by
- Rimawi, Mothaffar F
- Wiechmann, Lisa S
- Wang, Yen-Chao
- Huang, Catherine
- Migliaccio, Ilenia
- Wu, Meng-Fen
- Gutierrez, Carolina
- Hilsenbeck, Susan G
- Arpino, Grazia
- Massarweh, Suleiman
- Ward, Robin
- Soliz, Robert
- Osborne, C Kent
- Schiff, Rachel
Producer: 20110722
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
735.
|
Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. [electronic resource] by
- Morris, Patrick G
- Iyengar, Neil M
- Patil, Sujata
- Chen, Carol
- Abbruzzi, Alyson
- Lehman, Robert
- Steingart, Richard
- Oeffinger, Kevin C
- Lin, Nancy
- Moy, Beverley
- Come, Steven E
- Winer, Eric P
- Norton, Larry
- Hudis, Clifford A
- Dang, Chau T
Producer: 20140702
In:
Cancer vol. 119
Availability: No items available.
|
|
736.
|
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1. [electronic resource] by
- Werfel, Thomas A
- Elion, David L
- Rahman, Bushra
- Hicks, Donna J
- Sanchez, Violeta
- Gonzales-Ericsson, Paula I
- Nixon, Mellissa J
- James, Jamaal L
- Balko, Justin M
- Scherle, Peggy A
- Koblish, Holly K
- Cook, Rebecca S
Producer: 20191021
In:
Cancer research vol. 79
Availability: No items available.
|
|
737.
|
|
|
738.
|
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study). [electronic resource] by
- Patel, Tejal A
- Ensor, Joe E
- Creamer, Sarah L
- Boone, Toniva
- Rodriguez, Angel A
- Niravath, Poly A
- Darcourt, Jorge G
- Meisel, Jane L
- Li, Xiaoxian
- Zhao, Jing
- Kuhn, John G
- Rosato, Roberto R
- Qian, Wei
- Belcheva, Anna
- Schwartz, Mary R
- Kaklamani, Virginia G
- Chang, Jenny C
Producer: 20200226
In:
Breast cancer research : BCR vol. 21
Availability: No items available.
|
|
739.
|
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer. [electronic resource] by
- Sethunath, Vidyalakshmi
- Hu, Huizhong
- De Angelis, Carmine
- Veeraraghavan, Jamunarani
- Qin, Lanfang
- Wang, Nicholas
- Simon, Lukas M
- Wang, Tao
- Fu, Xiaoyong
- Nardone, Agostina
- Pereira, Resel
- Nanda, Sarmistha
- Griffith, Obi L
- Tsimelzon, Anna
- Shaw, Chad
- Chamness, Gary C
- Reis-Filho, Jorge S
- Weigelt, Britta
- Heiser, Laura M
- Hilsenbeck, Susan G
- Huang, Shixia
- Rimawi, Mothaffar F
- Gray, Joe W
- Osborne, C Kent
- Schiff, Rachel
Producer: 20200728
In:
Molecular cancer research : MCR vol. 17
Availability: No items available.
|
|
740.
|
|